NO FEE UNLESS WE WIN
FREE CASE REVIEW

Free Consultation
Call Now

817-870-2102

Guides & Insights

Dangerous Drugs & Devices

Injured by a defective drug or medical device? We litigate against pharmaceutical and device manufacturers.

110 articles How we handle Dangerous Drugs & Devices →

F.D.A. Investigates Multistate Outbreak of Cyclosporiasis

On August 6, 2013, the Food and Drug Administration (F.D.A.) issued updated information on the recent outbreak of cyclosporiasis occurring in several…

Continue reading »

F.D.A. Recall Issued on DePuy Orthopaedics-LPS Lower Extremity Dovetail Intercalary Component

On August 1, 2013, the Food and Drug Administration (F.D.A.) issued a Class I recall notice regarding DePuy Orthopaedics’ Limb Preservation System…

Continue reading »

La FDA Retira Producto “DePuy Orthopaedics-LPS Lower Extremity Dovetail Intercalary Component” Del Mercado

El 1 de agosto del 2013, la Administración de Alimentos y Medicamentos (FDA) publicó un anuncio acerca del retiro Clase I del…

Continue reading »

FDA Rule Could Allow Suits Against Generic Drug Makers

On July 3, 2013, the New York Times published an article commenting on the recent announcement from the U.S. Food and Drug…

Continue reading »

A Damaging Decision on Generic Drugs

On June 28, 2013, the New York Times published an editorial regarding the Supreme Court’s recent decision to reverse a $21 million…

Continue reading »

Supreme Court issues opinion reversing $21 million award in Mutual Pharmaceutical Co., Inc. v. Bartlett

On June 24, 2013, the Supreme Court reversed a $21 million jury verdict awarded to a woman who suffered serious and debilitating…

Continue reading »

FDA takes steps to tighten restrictions on metal-on-metal hip implants

On January 17, 2013, the U.S. Food and Drug Administration (FDA) issued new safety information and recommendations to patients and health care…

Continue reading »

Additional concerns emerge as fungal meningitis outbreak expands

The fungal meningitis outbreak, linked to contaminated steroids produced and distributed by New England Compounding Center (NECC), has grown to 214 cases…

Continue reading »

New warnings issued on hip resurfacing procedures

A recent study appearing in the online version of The Lancet warns of increased early failure rates for hip resurfacing implants. The…

Continue reading »

Plaintiffs seek consolidation of state court Stryker hip cases

On September 19, 2012, attorneys representing plaintiffs who have been injured by the Stryker Rejuvenate and ABG II modular hip implant devices…

Continue reading »

Hurt in a dangerous drugs & devices situation?

Free, confidential case review with a board-certified Texas trial lawyer. No fee unless we win.

Get a Free Case Review Call 817-870-2102
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.